Patents by Inventor Pierre Lagny

Pierre Lagny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110244062
    Abstract: The present invention relates to a composition inhibiting or destroying at least one living or unicellular organism, which comprises at least one anti-infectious agent and one activating agent, which consists of an extract made from dehydrated and partially sodium-free seawater or an extract made from a dried fossil sea with a similar composition. The present invention also relates to the utilization of such a composition.
    Type: Application
    Filed: February 14, 2011
    Publication date: October 6, 2011
    Applicant: AROMAPHARM IRELAND LTD.
    Inventors: Pierre LAGNY, Jean-Jacques HERAULT
  • Publication number: 20110206747
    Abstract: The present invention relates to a composition inhibiting or destroying at least one living or unicellular organism, which comprises at least one anti-infectious agent and at least one activating agent containing at least one metal element, together with at least one dispersing agent. The present invention also relates to the utilization of such a composition.
    Type: Application
    Filed: May 19, 2010
    Publication date: August 25, 2011
    Inventors: Pierre LAGNY, Jean-Jacques HERAULT
  • Patent number: 5800838
    Abstract: The invention is directed to a composition and a method for using the same which composition inhibits or destroys unicellular living organisms. The composition is particularly effective in combating sexually transmitted diseases and as an antiseptic agent. The composition of the invention comprises lithium and ionic or ionizable, fluorine, for example, lithium fluoride. A suitable excipient such as KATHON may also be present.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: September 1, 1998
    Assignee: Atlantic Pharmaceutical Products Limited
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 5798391
    Abstract: Solution administrable by intravascular injection in a human or an animal which comprises an effective amount up to 0.23% by weight of a benzalkonium fluoride having the formula: ##STR1## where R is an alkyl radical which may vary between C.sub.8 H.sub.17 and C.sub.18 H.sub.37, dissolved in an excipient injectable intravascularly. Preferably R is between C.sub.12 H.sub.25 and C.sub.14 H.sub.29, and more preferably C.sub.14 H.sub.29. The solution can be packaged in 10 ml ampoules, containing about 21 mg of benzalkonium fluoride, the benzalkonium fluoride being dissolved in a physiological solvent. The solution also contains at least one metallic derivative of fluorine, preferably lithium fluoride.
    Type: Grant
    Filed: October 22, 1996
    Date of Patent: August 25, 1998
    Assignee: Aromafarm Limited
    Inventors: Pierre Lagny, Pierre Bourbon
  • Patent number: 5762940
    Abstract: This invention relates to a method and composition for inhibiting or destroying viruses or retroviruses in a mammalian host. The method comprises contacting the viruses or retroviruses with a composition. The composition comprises an active ingredient capable of inhibiting or destroying viruses or retroviruses, for example, a surfactant, and an activating ingredient capable of inhibiting or destroying one or more enzymes associated with viruses or retroviruses, for example, a fluorinated compound capable of releasing fluoride anions, and an excipient.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 9, 1998
    Assignee: Atlantic Pharmaceutical Products Limited
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 5662941
    Abstract: The invention is directed to a composition and a method for using the same which composition inhibits or destroys unicellular living organisms. The composition is particularly effective in combating sexually transmitted diseases and as an antiseptic agent. The composition of the invention comprises lithium and ionic or ionizable, fluorine, for example, lithium fluoride. A suitable excipient such as KATHON may also be present.
    Type: Grant
    Filed: September 22, 1993
    Date of Patent: September 2, 1997
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 5458889
    Abstract: This invention relates to a method and composition for inhibiting or destroying viruses or retroviruses in a mammalian host. The method comprises contacting the viruses or retroviruses with a composition. The composition comprises an active ingredient capable of inhibiting or destroying viruses or retroviruses, for example, a surfactant, and an activating ingredient capable of inhibiting or destroying one or more enzymes associated with viruses or retroviruses, for example, a fluorinated compound capable of releasing fluoride anions, and an excipient.
    Type: Grant
    Filed: February 22, 1993
    Date of Patent: October 17, 1995
    Assignee: Atlantic Pharmaceutical Products Limited
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 5063064
    Abstract: The invention is directed to a composition and a method for preparing the same which composition inhibits or destroys unicellular living organisms. The composition is effective as a spermicide and also in combating sexually transmitted diseases and as an antiseptic agent. The composition of the invention comprises lithium and ionic or ionizable fluorine, for example, lithium fluoride. A suitable excipient such as KATHON may also be present. The invention may, for example, comprise lithium fluoride and a spermicidal agent, such as a quaternary ammonium compound, for example, benzalkonium chloride.
    Type: Grant
    Filed: September 20, 1988
    Date of Patent: November 5, 1991
    Assignee: Atlantic Pharmaceutical Products Ltd.
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 5026561
    Abstract: The invention relates to a method for inhibiting or destroying unicellular living organisms of a human or animal. The method comprises contacting the unicellular living organisms with the composition which comprises at least one quaternary ammonium salt and which may further comprises a metal fluoride for example, lithium fluoride. A preservative, such as Kathon (Registered Trademark) may also be present in the composition. The method is useful in inhibiting or destroying unicellular living organisms such as viruses or retroviruses, fungi, bacteria, or organisms which cause sexually transmittable diseases. The method may also be used to inhibit or destroy spermatozoa, or inhibit pathogenic microorganisms.
    Type: Grant
    Filed: September 20, 1988
    Date of Patent: June 25, 1991
    Assignee: Atlantic Pharmaceutical Products Limited
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot
  • Patent number: 4917901
    Abstract: The inventive composition comprises an active ingredient, for example a quaternary ammonium compound, which active ingredient is capable of inhibiting or destroying a unicellular living organism, such as spermatazoa, bacteria or virus. The active ingredient is combined in a synergistic amount with an activating ingredient capable of inhibiting or destroying the enzymes associated with the unicellular organism. The activating ingredient may be capable of releasing fluoride ions, for example, an inorganic fluoride compound. The composition according to the invention is useful, for example, as a spermicide, or as an antibiotic, or as an anti-STD preparation for local or topical application.
    Type: Grant
    Filed: May 22, 1987
    Date of Patent: April 17, 1990
    Assignee: Atlantic Pharmaceutical Products, Ltd.
    Inventors: Pierre Bourbon, Pierre Lagny, Pierre Billot